Breast Cancer Advice. Keep up to date with the latest information and treatment of breast cancer.
A Member of the Healthscout Network
 Printer Friendly  Send to a Friend

New Study on Hormone and Breast Cancer Therapy Link

Ivanhoe Newswire

(Ivanhoe Newswire) -- Taking estrogen plus testosterone therapy to treat menopause symptoms may increase a woman's risk of breast cancer.

Researchers from Brigham and Women's Hospital and Harvard Medical School in Boston looked at the long-term effects of the combination treatment in 121,700 women in the Nurses' Health Study. During 24 years of follow-up -- from 1978 to 2002 -- there were 4,610 cases of breast cancer among postmenopausal women.

Related Stories
Black Women's Genes May Spur Deadlier Breast Cancer
Breast Cancer Drugs Not One-Size-Fits-All
Digital Mammography Boosts Chances of Spotting Malignancies
Related Videos
Attacking Advanced Breast Cancer
Keep Ovarian Cancer At Bay
Easing Radiation Side Effects
Related Slides
Breast Cancer
Breast Self-Exam

Researchers found among women who went through menopause naturally, the risk of breast cancer was nearly 2.5-times greater among those who took estrogen plus testosterone than in women who had never had any hormone therapy. Results also reveal participants who took the combination therapy had a 77-percent higher risk of developing breast cancer than women who had never used hormones -- higher than the increased risk in women who took estrogen (15 percent) or in those who took estrogen plus progestin (58 percent).

Researchers say enzymes in the breast tissue may convert testosterone to estradiol -- an estrogen-like hormone that may contribute to the development of breast cancer.

The authors are concerned because the number of women who used the combined estrogen and testosterone therapy increased dramatically -- from 33 in 1988 to 550 in 1998.

They write, "Given the substantial evidence implicating combined estrogen plus progestin therapy in breast cancer and the results of the present study regarding estrogen plus testosterone therapy, women and their physicians should reconsider use and, more specifically, long-term use of these therapies. Although postmenopausal therapies may provide improvement with respect to sexual functioning, general well-being and bone health, the increased risk of breast cancer may outweigh the benefits."

This article was reported by, who offers Medical Alerts by e-mail every day of the week. To subscribe, go to:

SOURCE: Archives of Internal Medicine, 2006;166:1483-1489

Last updated 7/25/2006

Disclaimer: The information provided on this website is for educational purposes only and does not serve as a replacement for care provided by your own personal health care team. This website does not render or provide medical advice, and no individual should make any medical decisions or change their health behavior based on information provided here. All pertinent content provided on this website should be discussed with your personal physician to evaluate whether it has any relevance to or impact on your specific condition. Reliance on any information provided by this website is solely at your own risk.

Nov 14, 2006
New! For timely and trustworth health information, expert advice and much more, visit Breast Cancer Connection
Patient Guide
Health Videos
Health Encyclopedia
Health News Archive
Affiliate Information
HealthScout Network
Contact Us
Privacy Policy
Terms of Use

We subscribe to the HONcode principles of the Health On the Net Foundation
About The HealthScout Network Contact Us
Copyright 2001-2006 Choicemedia, Inc. All rights reserved.

Please visit our partner sites: